The Week Ahead: Fed...
Health Care: Drugs
Exact Sciences Corporation (EXAS: NASDAQ)
$9.55 -0.10 | -1.04%
06/04/12 - 12:25 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 4.16M | 5.34M | 4.76M | -867.00K |
| Cost of Sales | 3.76M | 5.11M | -155.00K | 726.00K |
| Gross Operating Profit | 407.00K | 232.00K | 4.91M | -1.59M |
| Selling, General, and Administrative Expenses | 10.99M | 8.12M | 9.78M | 6.47M |
| Research & Development | 21.97M | 9.02M | 4.21M | 2.03M |
| Operating Income before D & A (EBITDA) | -32.56M | -16.91M | -9.08M | -10.10M |
| Depreciation & Amortization | -3.73M | -5.09M | 175.00K | -725.00K |
| Interest Income | 169.00K | 26.00K | 119.00K | 232.00K |
| Other Income - Net | 0.00 | 244.00K | 0.00 | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -28.65M | -11.56M | -9.13M | -9.74M |
| Interest Expense | 21.00K | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -28.68M | -11.56M | -9.13M | -9.74M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -28.68M | -11.56M | -9.13M | -9.74M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -28.68M | -11.56M | -9.13M | -9.74M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -28.68M | -11.56M | -9.13M | -9.74M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-28.68M | -11.56M | -9.13M | -9.14M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -28.68M | -11.56M | -9.13M | -9.74M |
| Basic EPS from Continuing Ops. | -0.54 | -0.29 | -0.28 | -0.36 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.54 | -0.29 | -0.28 | -0.36 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.54 | -0.29 | -0.28 | -0.36 |
| Basic Normalized Net Income/Share | -0.54 | -0.29 | -0.28 | -0.34 |
| EPS fr Continuing Ops. | -0.54 | -0.29 | -0.28 | -0.36 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.54 | -0.29 | -0.28 | -0.36 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.54 | -0.29 | -0.28 | -0.36 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.54 | -0.29 | -0.28 | -0.34 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with EXAS
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- Contributor8 Health Care Stocks With R...
- Usergdean1
- Userradforj John's SEP & Ta...
- UserBlind Rookie
- Userbbrads Portfolio 1
- Userremodelit Portfolio 1
- UserGoBears Under $5 Stock Picks
- UserMornan
- Userjwpao Portfolio 1
Latest EXAS Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- Look to Exact Sciences, Not Radient Pharma, for Best Colon Cancer Screen Test 01.23.12 | 01:01 pm
- Biotech Stock Mailbag: YM Bio, Exact, Peregrine 12.09.11 | 06:12 am
- Exact Sciences Corporation (EXAS): CORRECTION 10.06.11 | 04:10 pm
- Exact Sciences' Colon Cancer Screening Trial 07.12.11 | 08:07 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- Biotech Stock Mailbag: Neoprobe 05.06.11 | 07:05 am
- Radient Pharma Readies Onko-Sure Data 03.29.11 | 02:03 pm
- Mayo Clinic Denies Test Link to Radient Pharma 03.07.11 | 05:03 pm
- Biotech Stock Mailbag: Exact Sciences 02.25.11 | 07:02 am
Press Releases for EXAS
- Exact Sciences To Participate In June Investor Conferences - Business Wire 05.30.12 | 10:05 am
- Exact Sciences Extends, Expands Relationship With Mayo Clinic - Business Wire 05.17.12 | 09:05 am
- Exact Sciences To Participate In May Investor Conferences - Business Wire 05.07.12 | 11:05 am
- Exact Sciences Reports First-Quarter 2012 Financial Results - Business Wire 05.01.12 | 07:05 am
- Exact Sciences To Host First-Quarter 2012 Results Webcast And Call - Business Wire 04.23.12 | 02:04 pm
- Exact Sciences’ Executives, Colon Cancer Challenge Leaders To Ring Nasdaq Opening Bell - Business Wire 03.19.12 | 09:03 am
- Exact Sciences To Participate In March Investor Conferences - Business Wire 02.29.12 | 11:02 am
- Exact Sciences Reports Fourth-Quarter, Full-Year 2011 Financial Results - Business Wire 02.23.12 | 07:02 am
- Exact Sciences Announces Appointment Of Stoltenberg As Chief Commercial Officer - Business Wire 02.20.12 | 04:02 pm
- Exact Sciences Promotes Arora To Chief Operating Officer - Business Wire 02.16.12 | 04:02 pm
Partner Headlines for EXAS
- UPDATE: Auriga Raises PT to $13 on EXACT Sciences - Benzinga 02.24.12 | 04:02 pm
- Exact Sciences Promotes Arora to Chief Operating Officer - Benzinga 02.16.12 | 04:02 pm
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers - Seeking Alpha 04.17.11 | 07:04 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- UPDATE1-New colon cancer test works without colonoscopy - Reuters 10.28.10 | 05:10 pm
- Detecting More Upside Potential for EXACT Sciences - Seeking Alpha 10.22.10 | 09:10 pm
- Piper Jaffray’s Top Picks for The Second Half of 2010 (CPHD, EXAS, GNMK) - Benzinga 08.24.10 | 09:08 am
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm
